Stockreport

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF The Company to host an earnings conference call via webcast AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a gl [Read more]